Biomarin Pharmaceutical Inc at RBC Capital Markets Healthcare Conference Transcript
Dr. Baffi, I'll go ahead and actually you introduce yourself, and then maybe we can start with a quick background on BioMarin and jump into more detailed session.
Sure. Nice to be here this morning. Thank you for the invitation. I'm the Executive Vice President of Technical Operations at BioMarin, responsible for overall quality, manufacturing, process sciences and engineering functions for the company. I'm responsible for producing not only our clinical products but our commercial products. We have 7 commercial products generating this year about $1.7 billion in revenue distributed in over 75 countries around the world. Mostly enzyme products, 5 enzymes and 2 small molecules. And as we get into the gene therapy discussion, we'll discuss how we've leveraged our experience in the biologics, that is the enzyme products, to really jump start our gene therapy program.
Questions & Answers
Perfect. Thank you
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
